Review
Published on 15 May 2025
Autophagy as a potential therapeutic target in regulating improper cellular proliferation
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1579183
- 1,613 views
Type at least 3 characters
2,895 articles
Original Research
Published on 15 May 2025
Preclinical studies of a PARP-targeted theranostic radiopharmaceutical for pancreatic cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1576587
- 1,074 views
Review
Published on 14 May 2025
Based on small molecules: development and application of fibroblast activation protein inhibitors radiopharmaceutical in tumor precision therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1593380
- 1,569 views
Original Research
Published on 14 May 2025
Valproic acid induces ferroptosis and suppresses the proliferation of MDA-MB-231 cells by targeting FDFT1
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1540667
- 1,025 views
Review
Published on 14 May 2025
The potential of targeting autophagy-related non-coding RNAs in the treatment of lung cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1551258
- 924 views
Review
Published on 12 May 2025
CDK4/6 inhibitors in breast cancer therapy: mechanisms of drug resistance and strategies for treatment
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1549520
- 1,695 views
Review
Published on 12 May 2025
Challenges and hope: latest research trends in the clinical treatment and prognosis of liposarcoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1529755
- 1,035 views
Review
Published on 12 May 2025
Bibliometric analysis of research trends on the combination of radiotherapy and PARP inhibitors in solid tumors
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1603573
- 1,167 views
Original Research
Published on 09 May 2025
Correlation analysis of pharmacokinetic parameters of docetaxel AUC and adverse reactions in breast cancer patients
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1563506
- 932 views
Review
Published on 08 May 2025
Cuproptosis-related genes and agents: implications in tumor drug resistance and future perspectives
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1559236
- 1,728 views
Review
Published on 06 May 2025
Plant polysaccharides influence tumor development based on epigenetics: a review
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1588857
- 1,568 views
Original Research
Published on 02 May 2025
Low-dose statins restore innate immune response in breast cancer cells via suppression of mutant p53
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1492305
- 1,569 views
Review
Published on 30 Apr 2025
Nanotechnology-driven strategies in postoperative cancer treatment: innovations in drug delivery systems
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1586948
- 1,076 views
Original Research
Published on 30 Apr 2025
Sulindac exhibits anti-proliferative and anti-invasive effects and enhances the sensitivity to paclitaxel in ovarian cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1520771
- 1,051 views
General Commentary
Published on 30 Apr 2025
Commentary: Triclabendazole induces pyroptosis by activating caspase-3 to cleave GSDME in breast cancer cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1583920
- 686 views
Case Report
Published on 29 Apr 2025
Case report: Durable response of immuno-chemotherapy targeting a rare ROS1 fusion-positive extensive-stage SCLC patient after primary resistance to crizotinib
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1522542
- 1,185 views